Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

GPCB

Gpc Biotech AG ADS (MM) (GPCB)

Gpc Biotech AG ADS (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GPCB
DateHeureSourceTitreSymboleSociété
21/04/200916h12Business WireNew Pre-Clinical Data on RGB-286638 Multi-Targeted Kinase Inhibitor Presented at AACRNASDAQ:GPCBGpc Biotech AG ADS (MM)
25/03/200907h40Business WireGPC Biotech Reports Financial Results for Fiscal Year 2008NASDAQ:GPCBGpc Biotech AG ADS (MM)
23/02/200920h17Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
18/02/200902h31Business WireGPC Biotech and Agennix Announce Proposed MergerNASDAQ:GPCBGpc Biotech AG ADS (MM)
09/12/200810h10Business WireGPC Biotech Opens Enrollment in Phase 1 Trial Evaluating RGB-286638 Multi-Targeted Protein Kinase Inhibitor in Patients with ...NASDAQ:GPCBGpc Biotech AG ADS (MM)
13/11/200807h40Business WireGPC Biotech Reports Financial Results For Third Quarter and First Nine Months of 2008NASDAQ:GPCBGpc Biotech AG ADS (MM)
06/11/200815h42Business WireGPC Biotech to Present at Rodman & Renshaw Annual Global Investment Conference in New YorkNASDAQ:GPCBGpc Biotech AG ADS (MM)
25/08/200821h13Edgar (US Regulatory)Gpc Biotech Ag - Report of Foreign Issuer (6-K)NASDAQ:GPCBGpc Biotech AG ADS (MM)
07/08/200800h01Business WireGPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for SatraplatinNASDAQ:GPCBGpc Biotech AG ADS (MM)
25/07/200822h15Business WireGPC Biotech Reports That Marketing Authorization Application for Satraplatin is to Be WithdrawnNASDAQ:GPCBGpc Biotech AG ADS (MM)
12/06/200810h05Business WireGPC Biotech Announces Granting of European Patent Related to Satraplatin for Treating Tumors Resistant or Refractory to TaxanesNASDAQ:GPCBGpc Biotech AG ADS (MM)
05/06/200808h49Business WireGPC Biotech to Present at Two Upcoming Conferences: 7th Annual Needham Biotechnology & Medical Technology Conference in New YorkNASDAQ:GPCBGpc Biotech AG ADS (MM)
02/06/200809h06Business WireData from Satraplatin SPARC Phase 3 Trial in Patients with Hormone-Refractory Prostate Cancer Progressing after Initial ChemotheNASDAQ:GPCBGpc Biotech AG ADS (MM)
02/06/200809h05Business WireNew Data from Several Satraplatin Clinical Trials in Solid Tumors Presented at 44th ASCO Annual MeetingNASDAQ:GPCBGpc Biotech AG ADS (MM)
28/05/200809h07Business WireGPC Biotech Announces Data from Several Satraplatin Clinical Trials to be Presented at ASCO Annual MeetingNASDAQ:GPCBGpc Biotech AG ADS (MM)
15/05/200808h36Business WireGPC Biotech Reports Financial Results for First Quarter 2008NASDAQ:GPCBGpc Biotech AG ADS (MM)
31/01/200819h42Edgar (US Regulatory)Gpc Biotech Ag - Amended Statement of Ownership (SC 13G/A)NASDAQ:GPCBGpc Biotech AG ADS (MM)
31/10/200704h35PR Newswire (US)GPC Biotech Today Announced Results of Survival Analysis from the SPARC TrialNASDAQ:GPCB
31/10/200704h27PR Newswire (US)Pharmion and GPC Biotech Announce Results of Overall Survival Analysis From the Satraplatin Pivotal Phase 3 TrialNASDAQ:GPCB
28/09/200717h12Edgar (US Regulatory)Gpc Biotech Ag (Other) (SC 13G)NASDAQ:GPCBGpc Biotech AG ADS (MM)
24/08/200700h00PR Newswire (US)Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLPNASDAQ:GPCBGpc Biotech AG ADS (MM)
23/08/200707h58PR Newswire (US)GPC Biotech Announces RestructuringNASDAQ:GPCB
21/08/200716h41PR Newswire (US)Finkelstein Thompson LLP Announces GPC Biotech AG InvestigationNASDAQ:GPCBGpc Biotech AG ADS (MM)
08/08/200708h37PR Newswire (US)GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2007NASDAQ:GPCB
02/08/200712h05PR Newswire (US)GPC Biotech Schedules Conference Call on August 8th to Discuss First Half 2007 Financial ResultsNASDAQ:GPCB
30/07/200715h57PR Newswire (US)GPC Biotech Withdraws Satraplatin NDA Filed for Accelerated ApprovalNASDAQ:GPCB
30/07/200715h48PR Newswire (US)GPC Biotech Withdraws Satraplatin NDA For Accelerated Approval; Plans to Resubmit With Survival AnalysisNASDAQ:GPCB
28/07/200704h30PR Newswire (US)Law Offices of Howard G. Smith Announces Class Action Lawsuit Against GPC BiotechNASDAQ:GPCBGpc Biotech AG ADS (MM)
27/07/200720h05PR Newswire (US)GPC Biotech AG Named in Purported Class Action Lawsuit in the United StatesNASDAQ:GPCB
27/07/200713h00PR Newswire (US)Marketing Authorization Application for Satraplatin Accepted for Review by the European Medicines AgencyNASDAQ:GPCB
 Showing the most relevant articles for your search:NASDAQ:GPCB

Dernières Valeurs Consultées

Delayed Upgrade Clock